Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ziziphus jujuba (Jujuboside A).
A dammarane-type triterpene saponin that modulates the GABAergic system and inhibits glutamate-mediated excitatory signaling to exert potent sedative, anxiolytic, and neuroprotective effects.
11211154
378.8 g/mol
3.6
N-(5-chloro-1,3-benzoxazol-2-yl)-3-(furan-3-yl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ziziphus jujuba (Jujuboside A) across standard consumer modalities.
The hygroscopic nature of concentrated Ziziphus extracts requires moisture-resistant HPMC shells and desiccants to prevent clumping and degradation of saponin content.
High concentrations of saponins can cause excessive foaming during the pectin cooking process and introduce a persistent bitter aftertaste that requires complex masking agents.
The high molecular weight of Jujuboside A (1207.3 g/mol) and the required therapeutic dose exceed the limited payload capacity of standard thin-film polymer matrices.
Ready to launch a product featuring Ziziphus jujuba (Jujuboside A)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Ziziphus jujuba (Jujuboside A) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Ziziphus jujuba (Jujuboside A) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation